Advances in Pharma Business Management and Research : Volume 1 / / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen.

This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Me...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Place / Publishing House:Cham : : Springer International Publishing :, Imprint: Springer,, 2020.
Year of Publication:2020
Edition:1st ed. 2020.
Language:English
Physical Description:1 online resource (X, 85 p. 11 illus.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993544272204498
ctrlnum (CKB)4100000010480423
(DE-He213)978-3-030-35918-8
(MiAaPQ)EBC6122108
(Au-PeEL)EBL6122108
(OCoLC)1143625864
(oapen)https://directory.doabooks.org/handle/20.500.12854/31058
(PPN)24298164X
(EXLCZ)994100000010480423
collection bib_alma
record_format marc
spelling Schweizer, Lars edt
Advances in Pharma Business Management and Research [electronic resource] : Volume 1 / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen.
1st ed. 2020.
Springer Nature 2020
Cham : Springer International Publishing : Imprint: Springer, 2020.
1 online resource (X, 85 p. 11 illus.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Open access Unrestricted online access star
Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management.
This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master’s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business.
Description based on publisher supplied metadata and other sources.
English
Pharmaceutical technology.
Health care management.
Health services administration.
Medical laws and legislation.
Pharmacy.
Pharmacy management.
Pharmaceutical Sciences/Technology. https://scigraph.springernature.com/ontologies/product-market-codes/B21010
Health Care Management. https://scigraph.springernature.com/ontologies/product-market-codes/527030
Medical Law. https://scigraph.springernature.com/ontologies/product-market-codes/R16005
Pharmacy. https://scigraph.springernature.com/ontologies/product-market-codes/F00008
Pharmacoeconomics and Health Outcomes. https://scigraph.springernature.com/ontologies/product-market-codes/H69020
Pharmaceutical Sciences/Technology
Health Care Management
Medical Law
Pharmacy
Pharmacoeconomics and Health Outcomes
Pharmaceutics
Health Care
Pharmacology
Pharma Management
Market Access
Regulatory Affairs
Research & Development
Quality Control
Open Access
Industrial chemistry & chemical engineering
Health economics
Medical & healthcare law
Pharmacy / dispensing
3-030-35917-4
Schweizer, Lars. editor. edt http://id.loc.gov/vocabulary/relators/edt
Dingermann, Theodor. editor. edt http://id.loc.gov/vocabulary/relators/edt
Russe, Otto Quintus. editor. edt http://id.loc.gov/vocabulary/relators/edt
Jansen, Christian. editor. edt http://id.loc.gov/vocabulary/relators/edt
language English
format Electronic
eBook
author2 Schweizer, Lars.
Schweizer, Lars.
Dingermann, Theodor.
Dingermann, Theodor.
Russe, Otto Quintus.
Russe, Otto Quintus.
Jansen, Christian.
Jansen, Christian.
author_facet Schweizer, Lars.
Schweizer, Lars.
Dingermann, Theodor.
Dingermann, Theodor.
Russe, Otto Quintus.
Russe, Otto Quintus.
Jansen, Christian.
Jansen, Christian.
author2_variant l s ls
l s ls
l s ls
t d td
t d td
o q r oq oqr
o q r oq oqr
c j cj
c j cj
author2_role HerausgeberIn
HerausgeberIn
HerausgeberIn
HerausgeberIn
HerausgeberIn
HerausgeberIn
HerausgeberIn
HerausgeberIn
author_sort Schweizer, Lars.
title Advances in Pharma Business Management and Research Volume 1 /
spellingShingle Advances in Pharma Business Management and Research Volume 1 /
Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management.
title_sub Volume 1 /
title_full Advances in Pharma Business Management and Research [electronic resource] : Volume 1 / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen.
title_fullStr Advances in Pharma Business Management and Research [electronic resource] : Volume 1 / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen.
title_full_unstemmed Advances in Pharma Business Management and Research [electronic resource] : Volume 1 / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen.
title_auth Advances in Pharma Business Management and Research Volume 1 /
title_new Advances in Pharma Business Management and Research
title_sort advances in pharma business management and research volume 1 /
publisher Springer Nature
Springer International Publishing : Imprint: Springer,
publishDate 2020
physical 1 online resource (X, 85 p. 11 illus.)
edition 1st ed. 2020.
contents Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management.
isbn 3-030-35918-2
3-030-35917-4
callnumber-first R - Medicine
callnumber-subject RS - Pharmacy
callnumber-label RS380
callnumber-sort RS 3380
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 615 - Pharmacology & therapeutics
dewey-full 615.19
dewey-sort 3615.19
dewey-raw 615.19
dewey-search 615.19
oclc_num 1143625864
work_keys_str_mv AT schweizerlars advancesinpharmabusinessmanagementandresearchvolume1
AT dingermanntheodor advancesinpharmabusinessmanagementandresearchvolume1
AT russeottoquintus advancesinpharmabusinessmanagementandresearchvolume1
AT jansenchristian advancesinpharmabusinessmanagementandresearchvolume1
status_str n
ids_txt_mv (CKB)4100000010480423
(DE-He213)978-3-030-35918-8
(MiAaPQ)EBC6122108
(Au-PeEL)EBL6122108
(OCoLC)1143625864
(oapen)https://directory.doabooks.org/handle/20.500.12854/31058
(PPN)24298164X
(EXLCZ)994100000010480423
carrierType_str_mv cr
is_hierarchy_title Advances in Pharma Business Management and Research Volume 1 /
author2_original_writing_str_mv noLinkedField
noLinkedField
noLinkedField
noLinkedField
noLinkedField
noLinkedField
noLinkedField
noLinkedField
_version_ 1787548899980869632
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05293nam a22008775i 4500</leader><controlfield tag="001">993544272204498</controlfield><controlfield tag="005">20230822223102.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr#nn#008mamaa</controlfield><controlfield tag="008">200219s2020 gw | o |||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-030-35918-2</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-030-35918-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000010480423</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-He213)978-3-030-35918-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)EBC6122108</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL6122108</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1143625864</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/31058</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PPN)24298164X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000010480423</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RS380</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RS190-210</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">TDCW</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED072000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">TDC</subfield><subfield code="2">thema</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">615.19</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schweizer, Lars</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advances in Pharma Business Management and Research</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">Volume 1 /</subfield><subfield code="c">edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2020.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Springer Nature</subfield><subfield code="c">2020</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer International Publishing :</subfield><subfield code="b">Imprint: Springer,</subfield><subfield code="c">2020.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (X, 85 p. 11 illus.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&amp;D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical &amp; Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&amp;D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master’s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical technology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Health care management.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Health services administration.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical laws and legislation.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacy.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacy management.</subfield></datafield><datafield tag="650" ind1="1" ind2="4"><subfield code="a">Pharmaceutical Sciences/Technology.</subfield><subfield code="0">https://scigraph.springernature.com/ontologies/product-market-codes/B21010</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Health Care Management.</subfield><subfield code="0">https://scigraph.springernature.com/ontologies/product-market-codes/527030</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Medical Law.</subfield><subfield code="0">https://scigraph.springernature.com/ontologies/product-market-codes/R16005</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Pharmacy.</subfield><subfield code="0">https://scigraph.springernature.com/ontologies/product-market-codes/F00008</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Pharmacoeconomics and Health Outcomes.</subfield><subfield code="0">https://scigraph.springernature.com/ontologies/product-market-codes/H69020</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharmaceutical Sciences/Technology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health Care Management</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medical Law</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharmacy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharmacoeconomics and Health Outcomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharmaceutics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health Care</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharmacology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharma Management</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Market Access</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Regulatory Affairs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Research &amp; Development</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Quality Control</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Open Access</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Industrial chemistry &amp; chemical engineering</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health economics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medical &amp; healthcare law</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharmacy / dispensing</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-030-35917-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schweizer, Lars.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dingermann, Theodor.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Russe, Otto Quintus.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jansen, Christian.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-08-24 03:06:04 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-03-09 01:44:44 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337594190004498&amp;Force_direct=true</subfield><subfield code="Z">5337594190004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337594190004498</subfield></datafield></record></collection>